Citius Pharmaceuticals, Inc.
CTXR- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001506251
No open-market purchases or sales by Citius Pharmaceuticals, Inc. insiders were filed in the last 90 days; 42 institutions reported holding it in 13F filings for Q2 2026, worth $822.4K in total; no superinvestor holds it.
13F holders, Q3 2025
Institutional positions in Citius Pharmaceuticals, Inc. as of Sep 30, 2025. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 34
- +3 vs. Q2 2025
- Shares held
- 624.4K
- −304.4K (−32.8%) vs. Q2 2025
- Total value
- $773.2K
- −$703.8K (−47.7%) vs. Q2 2025
- New holders
- 8
- 9 more added
- Sold out
- 5
- 4 more reduced
Compare with Q2 2025: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting CTXR on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 42 | $822.4K |
| Q1 2026 | 38 | $896.9K |
| Q4 2025 | 39 | $1.34M |
| Q3 2025 | 34 | $773.2K |
| Q2 2025 | 31 | $1.48M |
| Q1 2025 | 28 | $947.2K |
| Q4 2024 | 30 | $2.43M |
| Q3 2024 | 58 | $11.8M |
| Q2 2024 | 72 | $17.9M |
| Q1 2024 | 73 | $24.2M |
| Q4 2023 | 74 | $20.3M |
| Q3 2023 | 74 | $17.1M |
| Q2 2023 | 75 | $30.4M |
| Q1 2023 | 56 | $16.9M |
| Q4 2022 | 54 | $11.2M |
| Q3 2022 | 57 | $16.6M |
| Q2 2022 | 60 | $14.0M |
| Q1 2022 | 76 | $43.2M |
| Q4 2021 | 77 | $37.6M |
| Q3 2021 | 71 | $51.1M |
| Q2 2021 | 74 | $87.6M |
| Q1 2021 | 39 | $19.3M |
Institutions, Q3 2025
Shares, value and share of portfolio for each institution holding Citius Pharmaceuticals, Inc.; share changes are against Q2 2025.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Vanguard Group Inc | 166,390 | $206.3K | 0.00% | +86,287+107.7% | Added |
| Geode Capital Management, LLC | 119,771 | $148.5K | 0.00% | +43,676+57.4% | Added |
| BlackRock, Inc. | 69,851 | $86.6K | 0.00% | 00.0% | Unchanged |
| Susquehanna International Group, LLP | 48,186 | $59.8K | 0.00% | +33,987+239.4% | Added |
| Northern Trust Corp | 27,025 | $33.5K | 0.00% | +12,652+88.0% | Added |
| UBS Group AG | 25,913 | $32.1K | 0.00% | −167,014−86.6% | Reduced |
| GWM Advisors LLC | 25,400 | $31.5K | 0.00% | +400+1.6% | Added |
| State Street Corp | 23,271 | $28.9K | 0.00% | 00.0% | Unchanged |
| Two Sigma Investments, LP | 21,803 | $27.0K | 0.00% | +8,929+69.4% | Added |
| Arkadios Wealth Advisors | 20,000 | $24.8K | 0.00% | 00.0% | Unchanged |
| Jane Street Group, LLC | 18,885 | $23.4K | 0.00% | +18,885 | New |
| XTX Topco Ltd | 15,922 | $19.7K | 0.00% | −4,224−21.0% | Reduced |
| Cambridge Investment Research Advisors, Inc. | 10,044 | $12.0K | 0.00% | −173,490−94.5% | Reduced |
| Simplex Trading, LLC | 9,556 | $11.0K | 0.00% | +9,556 | New |
| IFP Advisors, Inc | 7,083 | $8.78K | 0.00% | 00.0% | Unchanged |
| Chelsea Counsel Co | 4,626 | $5.74K | 0.00% | 00.0% | Unchanged |
| SBI Securities Co., Ltd. | 4,020 | $4.99K | 0.00% | +20.0% | Added |
| Citigroup Inc | 1,617 | $2.00K | 0.00% | +1,617 | New |
| Advisor Group Holdings, Inc. | 1,487 | $1.98K | 0.00% | −200−11.9% | Reduced |
| Legacy Wealth Managment, LLC | 930 | $1.15K | 0.00% | +930 | New |
| Luminist Capital LLC | 435 | $596 | 0.00% | 00.0% | Unchanged |
| Bank of America Corp | 422 | $523 | 0.00% | +45+11.9% | Added |
| Morgan Stanley | 407 | $504 | 0.00% | +347+578.3% | Added |
| Farther Finance Advisors, LLC | 343 | $425 | 0.00% | +343 | New |
| Murphy & Mullick Capital Management Corp | 160 | $251 | 0.00% | 00.0% | Unchanged |
| Princeton Global Asset Management LLC | 160 | $198 | 0.00% | 00.0% | Unchanged |
| JPMorgan Chase & Co | 120 | $149 | 0.00% | 00.0% | Unchanged |
| Smallwood Wealth Investment Management, LLC | 120 | $148 | 0.00% | 00.0% | Unchanged |
| Quent Capital, LLC | 108 | $134 | 0.00% | +108 | New |
| BNP Paribas Arbitrage, SA | 107 | $133 | 0.00% | 00.0% | Unchanged |
| SRS Capital Advisors, Inc. | 84 | $104 | 0.00% | +84 | New |
| Federation des caisses Desjardins du Quebec | 80 | $99 | 0.00% | 00.0% | Unchanged |
| Fairscale Capital, LLC | 42 | $52 | 0.00% | 00.0% | Unchanged |
| Wells Fargo & Company | 40 | $50 | 0.00% | +40 | New |
| Heights Capital Management, Inc | 0 | $0 | 0.00% | −159,898−100.0% | Sold out |
| Bay Colony Advisory Group, Inc d/b/a Bay Colony Advisors | 0 | $0 | 0.00% | −16,500−100.0% | Sold out |
| Group One Trading, L.P. | 0 | $0 | 0.00% | −649−100.0% | Sold out |
| Raymond James Financial Inc | 0 | $0 | 0.00% | −226−100.0% | Sold out |
| Larson Financial Group LLC | 0 | $0 | 0.00% | −45−100.0% | Sold out |